Skip to main content

Table 3 Risk factors of placental malaria infection

From: Coverage and effectiveness of intermittent preventive treatment in pregnancy with sulfadoxine–pyrimethamine (IPTp-SP) on adverse pregnancy outcomes in the Mount Cameroon area, South West Cameroon

Variable

Category

PM % (n)

Unadjusted OR (95% CI)a

Adjusted OR (95% CI)b

p-value

Setting

Semi rural (238)

21.8 (52)

1.56 (0.99–2.56)

1.85 (1.12–3.04)

0.016

Semi urban (227)

15.0 (34)

REF

REF

Age group (years)c

< 21 (90)

27.8 (25)

2.48 (1.37–4.51)

NA

 

21–25 (144)

20.8 (30)

1.70 (0.98–2.95)

> 25 (231)

13.4 (31)

REF

Parity

Primiparae (139)

24.5 (34)

2.09 (1.19–3.68)

2.13 (1.19–3.81)

0.011

Secundiparae (132)

19.7 (26)

1.59 (0.87–2.88)

1.74 (0.94–3.23)

0.078

Multiparae (194)

13.4 (26)

REF

REF

 

IPTp-SP Dosage frequency

≥ 3 SP dose (203

21.7 (44)

1.66 (0.89–3.10)

2.36 (1.41–4.87)

0.021

2 SP dose (150)

17.3 (26)

1.26 (0.64–2.48)

1.43 (0.70–2.90)

0.324

≤ 1 dose (112)

14.3 (16)

REF

REF

 

Trimester of first ANC

First (33)

10.5 (9)

0.22 (0.10–0.52)

0.69 (0.25–1.80)

0.448

Second (339)

16.2 (55)

0.60 (0.34–1.05)

0.39 (0.20–0.74)

0.004

Third (90)

24.4 (22)

REF

REF

 

ITN usage

Yes (315)

19.0 (60)

1.12 (0.68–1.87)

1.02 (0.6–1.73)

0.941

No (150)

17.3 (17)

REF

  
  1. NA not applicable, IPTp-SP intermittent preventive treatment in pregnancy with sulfadoxine–pyrimethamine, ANC antenatal clinic, ITN insecticide-treated nets
  2. aValues calculated using confidence interval calculator
  3. bValues from multinominal regression analysis
  4. cAge variable not included in the final model due colinearaity with parity